Latest filing published 06 Jan 2026 for Mersana Therapeutics, Inc.. Read the official filing
Mohan Bala is a declared insider of Mersana Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 10 filings; the first trade dates from 25 October 2023 and the latest from 6 January 2026.
The open-market record consists of 2 sales worth €3,971, with no purchase. The rest of the record consists of 7 option exercises.
On 6 January 2026 came the latest disclosure, a transaction in Mersana Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations